Catalyst Wire Dossier Catalyst Wire Dossier

NNC0705-0001

· Novo Nordisk A/S
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for NNC0705-0001, covering 2026-03-11 to 2026-03-11. Get the full timeline:

Most recent: Clinical Trial Update: A Study to See How Safe a New Medicine (NNC0705-0001) is in Healthy People [Phase 1]

See pricing